Massachusetts General Hospital
Al -Jawahiri, Areej, M.
The goal of this research study is to determine whether a self-administered, psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT).
Bone Marrow Transplant Complications
Hematologic Malignancy
CARE Application
Usual Care
NA
This is a randomized clinical trial to determine whether a psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT). The CARE app was developed with the goal of addressing the needs of caregivers of HCT recipients. Participants will be randomized into one of two study groups: CARE app plus Usual Care versus Usual Care. Participation in this study is expected to last up to 100 days after HCT. It is expected that about 120 people will take part in this research study. The Leukemia and Lymphoma Society is supporting this research by providing funding.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 120 participants |
Masking : | NONE |
Primary Purpose : | SUPPORTIVE_CARE |
Official Title : | Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Caregivers of Patients Receiving Hematopoietic Cell Transplantation (HCT) |
Actual Study Start Date : | 2023-07-01 |
Estimated Primary Completion Date : | 2024-12-01 |
Estimated Study Completion Date : | 2025-12-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02215